Drug search by name
Daclizumab Subcutaneous and Dolutegravir
Determining the interaction of Daclizumab Subcutaneous and Dolutegravir and the possibility of their joint administration.
Check result:
Daclizumab Subcutaneous <> Dolutegravir
Relevance: 11.12.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Daclizumab Subcutaneous
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Daclizumab Subcutaneous-Dolutegravir 10 mg
- Daclizumab Subcutaneous-Dolutegravir 25 mg and 50 mg
- Daclizumab Subcutaneous-Dolutegravir and lamivudine
- Daclizumab Subcutaneous-Dolutegravir and rilpivirine
- Daclizumab Subcutaneous-Dolutegravir Sodium
- Daclizumab Subcutaneous-Dolutegravir Sodium And Lamivudine
- Dolutegravir-Dacogen
- Dolutegravir-Dacomitinib
- Dolutegravir-Dactinomycin
- Dolutegravir-Dactinomycin Injection
- Dolutegravir-Dactinomycin Intravenous
- Dolutegravir-Daklinza
Doktika World
Interaction with food and lifestyle
Disease interaction